Inventor · disambiguated record
Jill A. Livengood
Also filed as: LIVENGOOD JILL · LIVENGOOD JILL A · LIVENGOOD JILL ANN
20 granted patents·16 pending applications·14 citations·filing 2009–2024
91Inventor score
Top patents by PatentIndex Score
36 records- 0190US2025018006A1Compositions and Methods for Dengue Virus Chimeric Constructions in VaccinesTAKEDA VACCINES INC·Filed 2024·Application pending·0 cites
- 0285US2024325518A1Method for inactivating zika virus and for determining the completeness of inactivationTAKEDA VACCINES INC·Filed 2024·Application pending·0 cites
- 0384US12109260B2Zika vaccines and immunogenic compositions, and methods of using the sameTAKEDA VACCINES INC·Filed 2023·Granted Oct 8, 2024·0 cites·30 claims
- 0484US11931399B2Compositions and methods for dengue virus chimeric constructions in vaccinesTAKEDA VACCINES INC·Filed 2022·Granted Mar 19, 2024·0 cites·29 claims
- 0584US8871487B2Compositions, methods and uses for inducing viral growthSTINCHCOMB DAN T·Filed 2009·Granted Oct 28, 2014·6 cites·20 claims
- 0681US11478541B2Method for inactivating Zika virus and for determining the completeness of inactivationTAKEDA VACCINES INC·Filed 2018·Granted Oct 25, 2022·1 cites·17 claims
- 0780US11964008B2Method for inactivating zika virus and for determining the completeness of inactivationTAKEDA VACCINES INC·Filed 2022·Granted Apr 23, 2024·0 cites·30 claims
- 0879US12186363B2Compositions and methods for dengue virus chimeric constructions in vaccinesTAKEDA VACCINES INC·Filed 2021·Granted Jan 7, 2025·0 cites·30 claims
- 0979US10052374B2Compositions, methods and uses for dengue virus serotype-4 constructsTAKEDA VACCINES INC·Filed 2016·Granted Aug 21, 2018·2 cites·25 claims
- 1079US9783579B2Compositions and methods for dengue virus chimeric constructs in vaccinesSTINCHCOMB DAN T·Filed 2014·Granted Oct 10, 2017·2 cites·11 claims
- 1174US2024285747A1Zika vaccines and immunogenic compositions, and methods of using the sameTAKEDA VACCINES INC·Filed 2023·Application pending·0 cites
- 1272US9890362B2Compositions, methods and uses for inducing viral growthTAKEDA VACCINES INC·Filed 2014·Granted Feb 13, 2018·1 cites·45 claims
- 1372US2024024454A1Method for inactivating zika virus and related methodsTAKLEDA VACCINES INC·Filed 2023·Application pending·0 cites
- 1468US11648304B2Zika vaccines and immunogenic compositions, and methods of using the sameTAKEDA VACCINES INC·Filed 2018·Granted May 16, 2023·0 cites·11 claims
- 1568US2020061151A1Compositions and Methods for Dengue Virus Chimeric Constructs in VaccinesTAKEDA VACCINES INC·Filed 2019·Application pending·0 cites
- 1667US10898565B2Compositions, methods and uses for dengue virus serotype-4 constructsTAKEDA VACCINES INC·Filed 2018·Granted Jan 26, 2021·0 cites·17 claims
- 1767US10806781B2Compositions and methods for live, attenuated alphavirus formulationsTAKEDA VACCINES INC·Filed 2018·Granted Oct 20, 2020·0 cites·15 claims
- 1867US9408901B2Compositions, methods and uses for dengue virus serotype-4 constructsINVIRAGEN INC·Filed 2013·Granted Aug 9, 2016·2 cites·27 claims
- 1967US2023263880A1Compositions and methods for stabilizing flaviviruses with improved formulationsTAKEDA VACCINES INC·Filed 2023·Application pending·0 cites
- 2066US11730802B2Zika vaccines and immunogenic compositions, and methods of using the sameTAKEDA VACCINES INC·Filed 2018·Granted Aug 22, 2023·0 cites·67 claims
- 2165US10449231B2Compositions and methods for dengue virus chimeric constructs in vaccinesTAKEDA VACCINES INC·Filed 2017·Granted Oct 22, 2019·0 cites·14 claims
- 2264US2024216498A1Large-scale flaviviral vaccine production and manufactureTAKEDA VACCINES INC·Filed 2023·Application pending·0 cites
- 2362US11975062B2Zika vaccines and immunogenic compositions, and methods of using the sameTAKEDA VACCINES INC·Filed 2018·Granted May 7, 2024·0 cites·36 claims
- 2461US11701421B2Compositions and methods for stabilizing flaviviruses with improved formulationsTAKEDA VACCINES INC·Filed 2020·Granted Jul 18, 2023·0 cites·30 claims
- 2561US10632184B2Compositions and methods for stabilizing alphaviruses with improved formulationsTAKEDA VACCINES INC·Filed 2017·Granted Apr 28, 2020·0 cites·62 claims
- 2658US10137186B2Compositions and methods for live, attenuated alphavirus formulationsTAKEDA VACCINES INC·Filed 2014·Granted Nov 27, 2018·0 cites·15 claims
- 2757US2025134982A1Large-scale flaviviral vaccine production and manufactureTAKEDA VACCINES INC·Filed 2023·Application pending·0 cites
- 2857US2020306361A1Compositions and methods for stabilizing alphaviruses with improved formulationsTAKEDA VACCINES INC·Filed 2020·Application pending·0 cites
- 2957US2025127875A1Large-scale flaviviral vaccine production and manufactureTAKEDA VACCINES INC·Filed 2023·Application pending·0 cites
- 3054US2018251737A1Compositions, methods and uses for inducing viral growthTAKEDA VACCINES INC·Filed 2017·Application pending·0 cites
- 3153US2024361319A1Immunofocus assay for determining the titer of dengue virusesTAKEDA VACCINES INC·Filed 2022·Application pending·0 cites
- 3252US2025277278A1Qualitative and quantitative determination of single virus haplotypes in complex samplesTAKEDA VACCINES INC·Filed 2021·Application pending·0 cites
- 3352US2023204567A1Method for determining the potency of antigensTAKEDA VACCINES INC·Filed 2021·Application pending·0 cites
- 3450US10835597B2Compositions and methods for stabilizing flaviviruses with improved formulationsTAKEDA VACCINES INC·Filed 2017·Granted Nov 17, 2020·0 cites·45 claims
- 3544US2022332800A1Novel anti-zika virus antibodies and uses thereofTAKEDA VACCINES INC·Filed 2019·Application pending·0 cites
- 3638US2019106682A1Live, Attenuated Alphavirus Constructs and Methods and Uses ThereofTAKEDA VACCINES INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jill A. Livengood files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →